Obesity Surgery

, Volume 27, Issue 11, pp 3004–3005 | Cite as

Letter in Reply to Arno et al. “Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism”

  • Victor Ferreira
  • Josh J. Wang
  • Eric Villeneuve
  • Sophie Gosselin
Letter to the Editor


Compliance with Ethical Standards

Grant Support

No grant support was received.

Conflict of Interest

The authors declare that they have no conflict of interest.


  1. 1.
    Arno AG, Farré M, Rodríguez-Morató J, et al. Pharmacokinetics in morbid obesity: influence of two bariatric surgery techniques on paracetamol and caffeine metabolism. Obes Surg. Springer US. 40(6):1–8.Google Scholar
  2. 2.
    Dobrinas M, Cornuz J, Oneda B, et al. Impact of smoking, smoking cessation, and genetic polymorphisms on CYP1A2 activity and inducibility. Clin Pharmacol Ther. 2011;90(1):117–25.CrossRefPubMedGoogle Scholar
  3. 3.
    Faber MS, Fuhr U. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking. Clin Pharmacol Ther. 2004;76(2):178–84.CrossRefPubMedGoogle Scholar
  4. 4.
    Faber MS, Jetter A, Fuhr U. Assessment of CYP1A2 activity in clinical practice: why, how, and when? Basic Clin Pharmacol Toxicol. 2005;97(3):125–34.CrossRefPubMedGoogle Scholar
  5. 5.
    Vistisen K, Poulsen HE, Loft S. Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine. Carcinogenesis. 1992;13(9):1561–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Department of PharmacyMcGill University Health CentreMontrealCanada
  2. 2.McGill FRCP Emergency Medicine ProgramMontrealCanada
  3. 3.Department of Emergency MedicineMcGill University Health CentreMontrealCanada

Personalised recommendations